Surgical treatment for neuroendocrine carcinoma of the uterine cervix

Int J Gynaecol Obstet. 2007 Dec;99(3):225-8. doi: 10.1016/j.ijgo.2007.06.051. Epub 2007 Sep 27.

Abstract

Objective: To identify the best operative approach for neuroendocrine cervical carcinoma (NECC).

Methods: The records of surgically treated patients with stages IB to IIB NECC were reviewed.

Results: Of 10 patients who met the study criteria for NECC and underwent radical hysterectomy, 4 had pT1bN0, 4 had pT1bN1, 1 had pT2aN0, and 1 had pT2bN1 disease. Those with pT1bN1 or pT2bN1 disease received postoperative adjuvant radiotherapy and/or chemotherapy, and recurrence occurred in 7 patients (70%). Among these 7 patients, 5 (71%) had a primary NECC tumor with deep stromal invasion and 5 (71%) had extrauterine disease (parametrium and/or lymph node). The recurrences in 6 patients (86%) were located outside the pelvis (lung, liver, or brain). Stromal invasion was 6 mm or less in the 3 patients who did not experience disease recurrence.

Conclusions: Pelvic control by radical hysterectomy may not be beneficial for patients with NECC except for those with an early invasive lesion.

MeSH terms

  • Adult
  • Carcinoma, Neuroendocrine / pathology
  • Carcinoma, Neuroendocrine / surgery*
  • Chemotherapy, Adjuvant / methods
  • Disease-Free Survival
  • Female
  • Follow-Up Studies
  • Humans
  • Hysterectomy*
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplasm Recurrence, Local / prevention & control
  • Prognosis
  • Radiotherapy, Adjuvant
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / surgery*